News
The NIH Technology Transfer Program was honored with its record 7th “Deal of Distinction Award” at the 2025 Licensing Executives Society Annual Meeting. This award was given to NIH and its licensee Bavarian Nordic for the deal that led to the new chikungunya virus vaccine Vimkunya ®. Vimkunya
The National Institute for Allergy and Infectious Diseases (NIAID) was awarded an Excellence in Technology Transfer award from the 2021 Federal Laboratory Consortium (FLC) awards. The FLC gave out 33 awards across nine different technology transfer categories, in addition to a COVID-19 Response
Are you interested in licensing a COVID-19 vaccine? As the pandemic continues, a safe, affordable, and efficacious vaccine continues to be of urgent importance. Scientists at NIAID have developed a vaccine against COVID-19 by utilizing the well-characterized vesicular stomatitis virus (VSV) encoding
Abraham Lincoln was the only president to have applied for a patent. His invention was never commercialized. As a young man, Lincoln took a flat boat load of merchandise down the Mississippi River from his then home in New Salem, Illinois, to New Orleans, Louisiana. At one point the boat slid onto a